You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 127 No. 2, February 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  STUDIES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (21)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Eosinophilic Fasciitis Associated With Tryptophan Ingestion

A Manifestation of Eosinophilia-Myalgia Syndrome

Marsha L. Gordon, MD; Mark G. Lebwohl, MD; Robert G. Phelps, MD; Steven R. Cohen, MD; Raul Fleischmajer, MD

Arch Dermatol. 1991;127(2):217-220.


Abstract

• Recently, the ingestion of tryptophan has been associated with eosinophilia-myalgia syndrome, which is characterized by eosinophilia, myalgias, and several less consistently reported findings. We treated 13 patients who exhibited clinical features of eosinophilic fasciitis who were taking high-dose tryptophan before the onset of clinical symptoms. Twelve patients exhibited eosinophilia, with eosinophil counts ranging from 0.13 to 0.88. The remaining patient was taking oral corticosteroids when her eosinophil count was determined. Eight patients complained of myalgias. Other symptoms included arthralgias, pruritus, cutaneous burning, weakness, fever, rashes, malaise, edema, muscle spasms, and alopecia. 5-Hydroxyindoleacetic acid levels were elevated in four of the eight urine specimens that were tested. Our findings suggest that previously diagnosed cases of eosinophilic fasciitis may represent variants of tryptophan-associated eosinophilia-myalgia syndrome. Derangements in the metabolism of tryptophan may play a role in sclerotic diseases.

(Arch Dermatol. 1991;127:217-220)



Author Affiliations

From the Departments of Dermatology (Drs Gordon, Lebwohl, Phelps, and Fleischmajer) and Pathology (Dr Phelps), Mount Sinai Medical Center, New York, NY, and the Department of Dermatology, Beth Israel Medical Center, New York (Dr Cohen).


Footnotes

Accepted for publication October 16, 1990.

Reprint requests to the Department of Dermatology, Box 1048, Mount Sinai Medical Center, 5 E 98th St, New York, NY 10029 (Dr Gordon).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Idiopathic and L-Tryptophan-Associated Eosinophilic Fasciitis Before and After L-Tryptophan Contamination
Blauvelt and Falanga
Arch Dermatol 1991;127:1159-1166.
ABSTRACT  

Unraveling the Eosinophilia-Myalgia Syndrome
Silver
Arch Dermatol 1991;127:1214-1216.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.